Status:
UNKNOWN
Improvement in Baroreflex Sensitivity in OSAS
Lead Sponsor:
Nagoya University
Conditions:
Obstructive Sleep Apnea Syndrome
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure...
Eligibility Criteria
Inclusion
- obstructive sleep apnea syndrome
Exclusion
- diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00284037
Last Update
January 31 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya University of Health Sciences
Nagoya, Japan, 461-8673